Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Basil Al-Nakib"'
Autor:
Misfer Al-Ajmi, Jameela Al-Khaldi, Iqbal Siddique, Salim F. Owaid, Rosh Varghese, Haifa Asker, Basil Al-Nakib, Fuad Hasan
Publikováno v:
American Journal of Gastroenterology. 99:1733-1737
The hepatitis C virus (HCV) genotype is an important predictive parameter for the success of pegylated interferon plus ribavirin therapy. To date, most published therapeutic trials have enrolled patients infected mainly with HCV genotypes 1, 2, and 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5532674fe17f090a42fddde12d5e94
https://doi.org/10.1111/j.1572-0241.2004.40077.x
https://doi.org/10.1111/j.1572-0241.2004.40077.x
Autor:
Jameela Al-Khaldi, Haifa Asker, Misfer Al-Ajmi, Basil Al-Nakib, Iqbal Siddique, Fuad Hasan, Rosh Varghese, Salem Owayed
Publikováno v:
Scopus-Elsevier
Background A significant proportion of hepatitis C patients treated with unmodified interferon plus ribavirin fail to respond. The optimal therapy for these patients has not been established yet. The objective of this study was to assess the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d490dfd8dee2b8d6b575742b3c1aec09
https://doi.org/10.1177/135965350400900409
https://doi.org/10.1177/135965350400900409
Publikováno v:
Journal of Tropical Pediatrics. 44:371-375
This report summarizes our retrospective analysis of 173 colonoscopic examinations performed on 159 children over a period of 9 years in Kuwait. Ninety-six children were males, with a male to female ratio of 1.5 :1. The main indications for colonosco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2703f408c40a409e32a668a0b1a6af45
https://doi.org/10.1093/tropej/44.6.371
https://doi.org/10.1093/tropej/44.6.371
Publikováno v:
Medical Principles and Practice. 7:187-191
Objective: Propranolol, a β-adrenergic blocker, has been reported to reduce portal pressure in patients with alcoholic cirrhosis and thereby might be useful in the prophylaxis of variceal bleeding. Since it is not known if the response of patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40ca5beda0fd3e481b6151f4492509d8
https://doi.org/10.1159/000026040
https://doi.org/10.1159/000026040
Publikováno v:
Annals of Saudi Medicine. 17:279-282
Alfa-interferon is the standard treatment of chronic hepatitis B. However, the response rate varies widely in patients from different parts of the world, reflecting differences in the natural history of the disease and the immune reactivity of the po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5da21c331bbff8a087fc79e02515285
https://doi.org/10.5144/0256-4947.1997.279
https://doi.org/10.5144/0256-4947.1997.279
Autor:
Fuad, Hasan, Jameela, Al-Khaldi, Haifa, Asker, Misfer, Al-Ajmi, Salem, Owayed, Rosh, Varghese, Iqbal, Siddique, Basil, Al-Nakib
Publikováno v:
Antiviral therapy. 9(4)
A significant proportion of hepatitis C patients treated with unmodified interferon plus ribavirin fail to respond. The optimal therapy for these patients has not been established yet. The objective of this study was to assess the efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a9377c6b80b593f37f7535587ee6289
https://pubmed.ncbi.nlm.nih.gov/15456080
https://pubmed.ncbi.nlm.nih.gov/15456080
Publikováno v:
European journal of gastroenterologyhepatology. 16(7)
To assess the prognostic ability of the Cancer of the Liver Italian Programme (CLIP) score and compare it with the Okuda system in patients with hepatocellular carcinoma from the Middle East, where the majority (70%) present with intermediate or adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568bd14e8e22006954cd78e4dad6c8fc
https://pubmed.ncbi.nlm.nih.gov/15201581
https://pubmed.ncbi.nlm.nih.gov/15201581
Autor:
Adel Ahmad, Maharaj Sheikh, M.R.N. Nampoory, Suad Abdeen, Basil Al-Nakib, Luqman Thalib, Jan Kodaj, K.V. Johny, Fuad Hasan, Iqbal Siddique, Haifa Asker
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 15(3)
PURPOSE To assess the efficacy and safety of transjugular liver biopsy (TJLB) in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis treatment. MATERIALS AND METHODS Forty-six consecutive patients with liver disease who were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76a9398d09bde7b83d917f96fece56e
https://pubmed.ncbi.nlm.nih.gov/15028810
https://pubmed.ncbi.nlm.nih.gov/15028810
Autor:
Abraham Koshy, Basil. Al-Nakib, P. R. Hira, Siham Al-Mufti, Ganesh Gopalakrishnan, Khaleel A. Al-Awadi
Publikováno v:
Journal of Urology. 153:698-700
We studied 26 adult patients referred for cystoscopy: 13 consecutive patients with schistosome ova on bladder biopsy and antibodies to Schistosoma species in serum were classified as having urinary schistosomiasis, while 13 consecutive patients witho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d229c32b943d2d15e389321bbba1aa
https://doi.org/10.1016/s0022-5347(01)67690-0
https://doi.org/10.1016/s0022-5347(01)67690-0
Autor:
Fuad, Hasan, Jameela, al-Khaldi, Haifa, Asker, Rosh, Varghese, Iqbal, Siddique, Mohammed, al-Shammali, Maher, al-Kalaoui, Basil, al-Nakib
Publikováno v:
Hepato-gastroenterology. 50(54)
Interferon monotherapy has been shown to induce a sustained viral response in 30-40% of patients with HbeAg-positive chronic hepatitis B infection. Similarly, lamivudine monotherapy causes HBeAg seroconversion in less than 20% of patients treated for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aacaf10dd1ec966473438b1372617d01
https://pubmed.ncbi.nlm.nih.gov/14696461
https://pubmed.ncbi.nlm.nih.gov/14696461